fda warning bpc-157 unapproved peptide safety risks panel narrowly backs drugs favored by RFK Jr. and wellness influencers bpc-157 fda warning not approved

Methylenetetrahydrofolate reductase deficiency (homocystinuria type II) as a rare cause of rapidly progressive tetraspasticity and psychosis in a previously healthy adult

"When the Australian Crime Commission report was released in February this year, the report indicated AOD-9604 was not a banned substance

The trial, it should be said, was aided by a powerful placebo effect: Patients who received the placebo had a reduction of some 1.7 migraine days a month

Research on the closely related GHK-Cu demonstrates improved collagen production in treated skin compared to various controls including vitamin C cream and retinoic acid